These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 636957)

  • 21. Functional sites of bovine high molecular weight kininogen as a cofactor in kaolin-mediated activation of factor XII (Hageman factor).
    Sugo T; Ikari N; Kato H; Iwanaga S; Fujii S
    Biochemistry; 1980 Jul; 19(14):3215-20. PubMed ID: 7407043
    [No Abstract]   [Full Text] [Related]  

  • 22. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
    van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN
    Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of arginine residues in the coagulant activity of high molecular weight kininogen.
    Chang JJ; Scott CF; Colman RW
    Blood; 1986 Mar; 67(3):805-10. PubMed ID: 3633200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding and dissociation of Hageman factor, prekallikrein and high molecular weight kininogen in human plasma during contact activation.
    Nakahara M
    Biochem Pharmacol; 1980 May; 29(9):1247-54. PubMed ID: 6772195
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
    Wiggins RC
    J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor.
    Webster ME; Guimaraes JA; Kaplan AP; Colman RW; Pierce JV
    Adv Exp Med Biol; 1976; 70(00):285-99. PubMed ID: 937135
    [No Abstract]   [Full Text] [Related]  

  • 27. Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogen.
    Colman RW; Scott CF; Shames PV; Dayal V; Liu CY; Kirby EP
    Trans Assoc Am Physicians; 1979; 92():208-17. PubMed ID: 317690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The autoactivation of rabbit Hageman factor.
    Wiggins RC; Cochrane CC
    J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
    Mandle RJ; Colman RW; Kaplan AP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
    Bock PE; Shore JD; Tans G; Griffin JH
    J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
    Thompson RE; Mandle R; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between factor XII (Hageman factor), high molecular weight kininogen and prekallikrein.
    Chan JY; Habal FM; Burrowes CE; Movat HZ
    Thromb Res; 1976 Nov; 9(5):423-33. PubMed ID: 996830
    [No Abstract]   [Full Text] [Related]  

  • 39. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properties of sulfatides in factor-XII-dependent contact activation.
    Tans G; Griffin JH
    Blood; 1982 Jan; 59(1):69-75. PubMed ID: 6914902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.